iac-femoral [IFB],
femoral-femoral bypass [FFB]) are less morbid alternatives
but are also less durable.
A tremendous paradigm shift has occurred in the last two
decades in the treatment of AIOD.134 Although intersocietal
guidelines previously recommended endovascular procedures as primary treatment for more focal disease and traditional surgery for more diffuse disease,9,135 improvements in
technology and endovascular techniques have resulted in
